LT2513085T - Bicikliniai junginiai, kaip alfa4beta2 nikotino acetilcholino receptoriaus ligandai - Google Patents
Bicikliniai junginiai, kaip alfa4beta2 nikotino acetilcholino receptoriaus ligandaiInfo
- Publication number
- LT2513085T LT2513085T LTEP09818648.9T LT09818648T LT2513085T LT 2513085 T LT2513085 T LT 2513085T LT 09818648 T LT09818648 T LT 09818648T LT 2513085 T LT2513085 T LT 2513085T
- Authority
- LT
- Lithuania
- Prior art keywords
- acetylcholine receptor
- receptor ligands
- nicotinic acetylcholine
- bicyclic compounds
- bicyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2838CH2009 | 2009-11-18 | ||
| PCT/IN2009/000758 WO2011061751A1 (en) | 2009-11-18 | 2009-12-31 | BICYCLIC COMPOUNDS AS α4β2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2513085T true LT2513085T (lt) | 2016-12-27 |
Family
ID=42228992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP09818648.9T LT2513085T (lt) | 2009-11-18 | 2009-12-31 | Bicikliniai junginiai, kaip alfa4beta2 nikotino acetilcholino receptoriaus ligandai |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8735423B2 (lt) |
| EP (1) | EP2513085B1 (lt) |
| JP (1) | JP5536227B2 (lt) |
| KR (1) | KR101376145B1 (lt) |
| CN (1) | CN102741239B (lt) |
| CA (1) | CA2773409C (lt) |
| CY (1) | CY1118361T1 (lt) |
| DK (1) | DK2513085T3 (lt) |
| EA (1) | EA020506B1 (lt) |
| ES (1) | ES2601905T3 (lt) |
| HK (1) | HK1175782A1 (lt) |
| HR (1) | HRP20161461T1 (lt) |
| HU (1) | HUE033352T2 (lt) |
| IL (1) | IL219637A (lt) |
| LT (1) | LT2513085T (lt) |
| MX (1) | MX2012005637A (lt) |
| NZ (1) | NZ600536A (lt) |
| PL (1) | PL2513085T3 (lt) |
| PT (1) | PT2513085T (lt) |
| RS (1) | RS55469B1 (lt) |
| SI (1) | SI2513085T1 (lt) |
| SM (1) | SMT201600444B (lt) |
| WO (1) | WO2011061751A1 (lt) |
| ZA (1) | ZA201203522B (lt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS54888B1 (sr) * | 2011-06-17 | 2016-10-31 | Lilly Co Eli | Derivati biciklo(3.1.0)heksan-2,6-dikarboksilne kiseline kao agonisti mglu2 receptora |
| JP6103240B2 (ja) | 2013-11-18 | 2017-03-29 | トヨタ紡織株式会社 | ピッチ材料の調整方法及び調整装置 |
| EP3634408B1 (en) * | 2017-06-09 | 2022-12-28 | Merck Sharp & Dohme LLC | Azabicyclo[4.1.0]heptane allosteric modulators of the m4 muscarinic acetylcholine receptor |
| WO2023135528A1 (en) | 2022-01-11 | 2023-07-20 | Suven Life Sciences Limited | Heteroalicyclic derivatives and their use in the treatment of cns disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4337341A (en) | 1976-11-02 | 1982-06-29 | Eli Lilly And Company | 4a-Aryl-octahydro-1H-2-pyrindines |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| AU7871498A (en) * | 1996-12-20 | 1998-07-17 | Novo Nordisk A/S | A method of treating hypercholesterolemia and related disorders |
| CN1391473A (zh) * | 1999-06-30 | 2003-01-15 | 第一制药株式会社 | Vla－4抑制剂化合物 |
| JP2004534026A (ja) | 2001-05-05 | 2004-11-11 | スミスクライン ビーチャム パブリック リミテッド カンパニー | オレキシン受容体アンタゴニストとしてのｎ−アロイルサイクリックアミン誘導体 |
| FR2889187B1 (fr) | 2005-07-28 | 2007-09-07 | Servier Lab | Nouveaux composes 1,1-pyridinyloxycyclopropanamines polysusbstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TWI454262B (zh) | 2006-11-02 | 2014-10-01 | Targacept Inc | 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺 |
-
2009
- 2009-12-31 HU HUE09818648A patent/HUE033352T2/en unknown
- 2009-12-31 CN CN200980162485.1A patent/CN102741239B/zh active Active
- 2009-12-31 KR KR1020127008755A patent/KR101376145B1/ko active IP Right Grant
- 2009-12-31 SI SI200931545A patent/SI2513085T1/sl unknown
- 2009-12-31 ES ES09818648.9T patent/ES2601905T3/es active Active
- 2009-12-31 LT LTEP09818648.9T patent/LT2513085T/lt unknown
- 2009-12-31 EP EP09818648.9A patent/EP2513085B1/en active Active
- 2009-12-31 CA CA2773409A patent/CA2773409C/en active Active
- 2009-12-31 PT PT98186489T patent/PT2513085T/pt unknown
- 2009-12-31 US US13/499,998 patent/US8735423B2/en active Active
- 2009-12-31 MX MX2012005637A patent/MX2012005637A/es active IP Right Grant
- 2009-12-31 RS RS20160961A patent/RS55469B1/sr unknown
- 2009-12-31 JP JP2012539471A patent/JP5536227B2/ja active Active
- 2009-12-31 WO PCT/IN2009/000758 patent/WO2011061751A1/en active Application Filing
- 2009-12-31 EA EA201290344A patent/EA020506B1/ru unknown
- 2009-12-31 PL PL09818648T patent/PL2513085T3/pl unknown
- 2009-12-31 DK DK09818648.9T patent/DK2513085T3/en active
- 2009-12-31 NZ NZ600536A patent/NZ600536A/xx unknown
-
2012
- 2012-05-07 IL IL219637A patent/IL219637A/en active IP Right Grant
- 2012-05-15 ZA ZA2012/03522A patent/ZA201203522B/en unknown
-
2013
- 2013-03-13 HK HK13103118.6A patent/HK1175782A1/xx unknown
-
2016
- 2016-11-04 HR HRP20161461TT patent/HRP20161461T1/hr unknown
- 2016-11-07 CY CY20161101138T patent/CY1118361T1/el unknown
- 2016-12-06 SM SM201600444T patent/SMT201600444B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201007527B (en) | Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands | |
| HK1163676A1 (en) | Bicyclic heterocyclic compound | |
| HK1177458A1 (en) | Substituted imidazopyridinyl aminopyridine compounds | |
| EP2351743A4 (en) | BICYCLIC CONNECTION | |
| HK1169106A1 (en) | Process for preparing azabicyclic compounds | |
| ZA201201635B (en) | Novel bicyclic urea compounds | |
| EP2464650A4 (en) | PROCESSES FOR PREPARING PEMETREXED | |
| HK1176606A1 (en) | 2-pyridone compounds 2- | |
| ZA201204562B (en) | 4b2 neuronal nicotinic acetylcholine receptor ligands | |
| ZA201106221B (en) | Bicyclic heterocyclic spiro compounds | |
| IL219637A (en) | Bicyclic compounds such as ligands for the 2ß4a nicotinic acetylcholine receptor | |
| IL219366A0 (en) | Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands | |
| HK1180955A1 (en) | Heterocyclyl compounds as histamine h3 receptor ligands h3 | |
| IL209817A0 (en) | Methods of preparing imidazole-based bicyclic compounds | |
| ZA201100805B (en) | Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands | |
| TH106311B (th) | สารประกอบควินูคลีดีนในฐานะเป็นลิแกนด์ของตัวรับแอลฟา-7 นิโคทินิค แอเซทิลโคลีน | |
| TH1201002302B (th) | สารประกอบไบไซคลิกในฐานะเป็นลิแกนด์ของตัวรับ อัลฟา4 เบตา2 นิโคทินิกแอซีทิลโคลีน | |
| TWM372255U (en) | Decoration structure for pillar | |
| IL214295A0 (en) | Bicyclic heterocyclic spiro compounds |